SFS 2015:245 Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor

<div><style type="text/css"> <!-- p {margin: 0; padding: 0;} .ft10{font-size:14px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft11{font-size:27px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft12{font-size:19px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft13{font-size:8px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft14{font-size:7px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft15{font-size:12px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft16{font-size:19px;line-height:19px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft17{font-size:14px;line-height:17px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft18{font-size:12px;line-height:14px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft19{font-size:12px;line-height:12px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft110{font-size:12px;line-height:15px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft20{font-size:14px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft21{font-size:15px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft22{font-size:14px;font-family:EMDKIG+TimesNewRomanPS;color:#000000;} .ft23{font-size:8px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft24{font-size:7px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft25{font-size:12px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft26{font-size:15px;line-height:17px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft27{font-size:14px;line-height:17px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft30{font-size:14px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft31{font-size:15px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft32{font-size:14px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft33{font-size:8px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft34{font-size:12px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft35{font-size:14px;line-height:17px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft40{font-size:14px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft41{font-size:15px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft42{font-size:12px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft43{font-size:14px;line-height:17px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft50{font-size:14px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} .ft51{font-size:15px;font-family:EMDKGE+TimesNewRomanPS;color:#000000;} .ft52{font-size:14px;line-height:17px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft60{font-size:8px;font-family:EMDKFD+TimesNewRomanPS;color:#000000;} --> </style> <div id="page1-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:646px;white-space:nowrap" class="ft10">1</p> <p style="position:absolute;top:80px;left:77px;white-space:nowrap" class="ft11"><b>Svensk f�rfattningssamling</b></p> <p style="position:absolute;top:187px;left:77px;white-space:nowrap" class="ft16"><b>F�rordning<br/>om �ndring i f�rordningen (1999:58) om f�rbud <br/>mot vissa h�lsofarliga varor;</b></p> <p style="position:absolute;top:263px;left:77px;white-space:nowrap" class="ft10">utf�rdad den 30 april 2015.</p> <p style="position:absolute;top:298px;left:91px;white-space:nowrap" class="ft10">Regeringen f�reskriver</p> <p style="position:absolute;top:296px;left:224px;white-space:nowrap" class="ft13">1 att bilagan till f�rordningen (1999:58) om f�rbud</p> <p style="position:absolute;top:315px;left:77px;white-space:nowrap" class="ft10">mot vissa h�lsofarliga varor ska ha f�ljande lydelse.</p> <p style="position:absolute;top:351px;left:91px;white-space:nowrap" class="ft10">Denna f�rordning tr�der i kraft den 9 juni 2015.</p> <p style="position:absolute;top:386px;left:77px;white-space:nowrap" class="ft10">P� regeringens v�gnar</p> <p style="position:absolute;top:421px;left:77px;white-space:nowrap" class="ft10">GABRIEL WIKSTR�M</p> <p style="position:absolute;top:438px;left:307px;white-space:nowrap" class="ft17">Lars Hedengran<br/>(Socialdepartementet)</p> <p style="position:absolute;top:898px;left:77px;white-space:nowrap" class="ft19">1 Se Europaparlamentets och r�dets direktiv 98/34/EG av den 22 juni 1998 om ett in-<br/>formationsf�rfarande betr�ffande tekniska standarder och f�reskrifter och betr�ffande<br/>f�reskrifter f�r informationssamh�llets tj�nster.</p> <p style="position:absolute;top:175px;left:536px;white-space:nowrap" class="ft12"><b>SFS 2015:245</b></p> <p style="position:absolute;top:202px;left:536px;white-space:nowrap" class="ft110">Utkom fr�n trycket<br/>den 12 maj 2015</p> </div> <div id="page2-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft20">2</p> <p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft21"><b>SFS 2015:245</b></p> <p style="position:absolute;top:51px;left:581px;white-space:nowrap" class="ft22"><i>Bilaga</i></p> <p style="position:absolute;top:49px;left:619px;white-space:nowrap" class="ft23">2</p> <p style="position:absolute;top:94px;left:181px;white-space:nowrap" class="ft26"><b>F�rteckning �ver varor som ska anses som h�lsofarliga varor <br/>enligt lagen om f�rbud mot vissa h�lsofarliga varor</b></p> <p style="position:absolute;top:138px;left:196px;white-space:nowrap" class="ft27">N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB)<br/>1-(3,4-metylendioxifenyl)-2-butylamin (BDB)<br/>5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)<br/>5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)<br/>5-metoxi-alfametyltryptamin (5-MeO-AMT)<br/>2,5-dimetoxi-4-etylfenetylamin (2C-E)<br/>alfa-metyltryptamin (AMT)<br/>2,5-dimetoxi-4-klorfenetylamin (2C-C)<br/>2,5-dimetoxi-4-metylfenetylamin (2C-D)<br/>4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT)<br/>4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT)<br/>gammabutyrolakton (GBL)<br/>1,4-butandiol (1,4-BD)<br/>4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT)<br/>4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)<br/>4-acetoxi-N,N-dietyltryptamin (4-AcO-DET)<br/>4-hydroxi-N,N-dietyltryptamin (4-HO-DET)<br/>1-(3-trifluormetylfenyl)piperazin (TFMPP)<br/>2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)<br/>[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-</p> <p style="position:absolute;top:486px;left:181px;white-space:nowrap" class="ft20">bensoxazin-6-yl]-1-naftalenylmetanon (WIN 55,212-2)</p> <p style="position:absolute;top:503px;left:196px;white-space:nowrap" class="ft20">5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]fenol</p> <p style="position:absolute;top:520px;left:181px;white-space:nowrap" class="ft20">(CP 55,940)</p> <p style="position:absolute;top:538px;left:196px;white-space:nowrap" class="ft27">(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007)<br/>(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015)<br/>(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019)<br/>2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat)<br/>4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098)<br/>1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147)<br/>(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4)<br/>4-metylhexan-2-amin (DMAA)<br/>4-(2-aminopropyl)bensofuran (4-APB)<br/>5-(2-aminopropyl)bensofuran (5-APB)<br/>6-(2-aminopropyl)bensofuran (6-APB)<br/>(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyclopropyl)metanon </p> <p style="position:absolute;top:747px;left:181px;white-space:nowrap" class="ft20">(UR-144)</p> <p style="position:absolute;top:764px;left:196px;white-space:nowrap" class="ft27">1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB)<br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:780px;left:407px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indol-3-karboxamid</p> <p style="position:absolute;top:799px;left:181px;white-space:nowrap" class="ft20">(STS-135) </p> <p style="position:absolute;top:816px;left:196px;white-space:nowrap" class="ft20">1-pentyl-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:814px;left:351px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indol-3-karboxamid<i> </i>(APICA</p> <p style="position:absolute;top:834px;left:181px;white-space:nowrap" class="ft20">[JWH-018 adamantyl karboxamid])</p> <p style="position:absolute;top:851px;left:196px;white-space:nowrap" class="ft20">1-pentyl-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:849px;left:351px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indazol-3-karboxamid</p> <p style="position:absolute;top:868px;left:181px;white-space:nowrap" class="ft20">(AKB48)</p> <p style="position:absolute;top:886px;left:196px;white-space:nowrap" class="ft20">(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.1</p> <p style="position:absolute;top:884px;left:425px;white-space:nowrap" class="ft23">3,7]dek-1-yl-metanon (AB-001)</p> <p style="position:absolute;top:921px;left:181px;white-space:nowrap" class="ft24">2 Senaste lydelse 2014:1481.</p> </div> <div id="page3-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:649px;white-space:nowrap" class="ft30">3</p> <p style="position:absolute;top:51px;left:536px;white-space:nowrap" class="ft31"><b>SFS 2015:245</b></p> <p style="position:absolute;top:51px;left:91px;white-space:nowrap" class="ft30">(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)met-</p> <p style="position:absolute;top:68px;left:77px;white-space:nowrap" class="ft30">anon (5F-UR-144<b>)</b></p> <p style="position:absolute;top:85px;left:91px;white-space:nowrap" class="ft35">1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-kinolinester (5F-PB22)<br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:101px;left:303px;white-space:nowrap" class="ft33">3,7]dek-1-yl-1H-indazol-3-karbox-</p> <p style="position:absolute;top:120px;left:77px;white-space:nowrap" class="ft30">amid (5F-AKB48)</p> <p style="position:absolute;top:138px;left:91px;white-space:nowrap" class="ft30">1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018 </p> <p style="position:absolute;top:155px;left:77px;white-space:nowrap" class="ft30">N-[5-kloropentyl] derivat)</p> <p style="position:absolute;top:172px;left:91px;white-space:nowrap" class="ft30">N-[1-(aminokarbonyl)-2-metylpropyl]-1-[(4-fluorofenyl)metyl]-1H-inda-</p> <p style="position:absolute;top:190px;left:77px;white-space:nowrap" class="ft30">zol-3-karboxamid (AB-FUBINACA)</p> <p style="position:absolute;top:207px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-((4-fluorofenyl)metyl)-1H-in-</p> <p style="position:absolute;top:225px;left:77px;white-space:nowrap" class="ft30">dazol-3-karboxamid (ADB-FUBINACA)</p> <p style="position:absolute;top:242px;left:91px;white-space:nowrap" class="ft30">N-[1-(aminokarbonyl)-2-metylpropyl]-1-(cyclohexylmetyl)-1H-indazol-3-</p> <p style="position:absolute;top:259px;left:77px;white-space:nowrap" class="ft30">karboxamid (AB-CHMINACA)</p> <p style="position:absolute;top:277px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid</p> <p style="position:absolute;top:294px;left:77px;white-space:nowrap" class="ft30">(AB-PINACA)</p> <p style="position:absolute;top:312px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-</p> <p style="position:absolute;top:329px;left:77px;white-space:nowrap" class="ft30">karboxamid (5F-AB-PINACA)</p> <p style="position:absolute;top:346px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-karboxa-</p> <p style="position:absolute;top:364px;left:77px;white-space:nowrap" class="ft30">mid (ADBICA)</p> <p style="position:absolute;top:381px;left:91px;white-space:nowrap" class="ft35">kinolin-8-yl-1-pentyl-1H-indol-3-karboxylat (PB-22)<br/>kinolin-8-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FUB-PB-22)<br/>naftalen-1-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FDU-PB-22)<br/>kinolin-8-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-PB-22 </p> <p style="position:absolute;top:451px;left:77px;white-space:nowrap" class="ft30">indazol)</p> <p style="position:absolute;top:468px;left:91px;white-space:nowrap" class="ft35">kinolin-8-yl-1-(cyklohexylmetyl)-1H-indol-3-karboxylat (BB-22) <br/>4-hydroxi-3,3,4-trimetyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on </p> <p style="position:absolute;top:503px;left:77px;white-space:nowrap" class="ft30">(4-HTMPIPO)</p> <p style="position:absolute;top:520px;left:91px;white-space:nowrap" class="ft30">(1-heptyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)metanon </p> <p style="position:absolute;top:538px;left:77px;white-space:nowrap" class="ft30">(UR-144-heptylderivat)</p> <p style="position:absolute;top:555px;left:91px;white-space:nowrap" class="ft35">N-bensyl-1-(5-fluoropentyl)-1H-indol-3-karboxamid (5F-SDB-006)<br/>N-bensyl-1-pentyl-1H-indol-3-karboxamid (SDB-006)<br/>N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karbox-</p> <p style="position:absolute;top:607px;left:77px;white-space:nowrap" class="ft30">amid (ADB-PINACA)</p> <p style="position:absolute;top:625px;left:91px;white-space:nowrap" class="ft35">N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid (MN-18)<br/>1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indol-3-karboxamid (5F-NNEI)<br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-kar-</p> <p style="position:absolute;top:677px;left:77px;white-space:nowrap" class="ft30">boxamid (5F-AB-144)</p> <p style="position:absolute;top:694px;left:91px;white-space:nowrap" class="ft35">(1-(5-fluoropentyl)-1H-indazol-3-yl)(naftalen-1-yl)metanon (THJ-2201)<br/>[1-(5-fluoropentyl)-1H-benso[d]imidazol-2-yl](naftalen-1-yl)metanon</p> <p style="position:absolute;top:729px;left:77px;white-space:nowrap" class="ft30">(FUBIMINA)</p> <p style="position:absolute;top:747px;left:91px;white-space:nowrap" class="ft30">metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karboxamido)-3-metylbutanoat</p> <p style="position:absolute;top:764px;left:77px;white-space:nowrap" class="ft30">(5F-AMB)</p> <p style="position:absolute;top:781px;left:91px;white-space:nowrap" class="ft30">1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indazol-3-karboxamid (5F-MN-</p> <p style="position:absolute;top:799px;left:77px;white-space:nowrap" class="ft30">18)</p> <p style="position:absolute;top:816px;left:91px;white-space:nowrap" class="ft30">1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-pyrrolo[3,2-c]pyridin-3-karbo-</p> <p style="position:absolute;top:834px;left:77px;white-space:nowrap" class="ft30">xamid (5F-PCN)</p> <p style="position:absolute;top:851px;left:91px;white-space:nowrap" class="ft35">naftalen-1-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-SDB-005)<br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-[(2-fluorofenyl)metyl]-1H-inda-</p> <p style="position:absolute;top:886px;left:77px;white-space:nowrap" class="ft30">zol-3-karboxamid (AB-FUBINACA 2-fluorobensyl isomer)</p> <p style="position:absolute;top:903px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-inda-</p> <p style="position:absolute;top:921px;left:77px;white-space:nowrap" class="ft30">zol-3-karboxamid (ADB-CHMINACA)</p> </div> <div id="page4-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft40">4</p> <p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft41"><b>SFS 2015:245</b></p> <p style="position:absolute;top:51px;left:196px;white-space:nowrap" class="ft40">7-kloro-N-[1-[((2-((cyklopropylsulfonyl)amino)-etyl)amino)karbonyl]-</p> <p style="position:absolute;top:68px;left:181px;white-space:nowrap" class="ft43">2,2-dimetyl-propyl]-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (ADSB-<br/>FUB-187)</p> <p style="position:absolute;top:103px;left:196px;white-space:nowrap" class="ft40">adamant-1-yl-(1-[(N-metylpiperidin-2-yl)metyl]-1H-indol-3-yl)metanon</p> <p style="position:absolute;top:120px;left:181px;white-space:nowrap" class="ft40">(AM-1248)</p> <p style="position:absolute;top:138px;left:196px;white-space:nowrap" class="ft40">N-(2-fenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-karboxamid</p> <p style="position:absolute;top:155px;left:181px;white-space:nowrap" class="ft40">(CUMYL-5F-PICA)</p> <p style="position:absolute;top:172px;left:196px;white-space:nowrap" class="ft40">1-(5-fluoropentyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid</p> <p style="position:absolute;top:190px;left:181px;white-space:nowrap" class="ft40">(CUMYL-5F-PINACA, SGT-25)</p> <p style="position:absolute;top:207px;left:196px;white-space:nowrap" class="ft43">1-butyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid (CUMYL-BICA)<br/>N-(2-fenylpropan-2-yl)-1-pentyl-1H-indol-3-karboxamid (CUMYL-PICA)<br/>N-(2-fenylpropan-2-yl)-1-pentyl-1H-indazol-3-karboxamid (CUMYL-PI-</p> <p style="position:absolute;top:259px;left:181px;white-space:nowrap" class="ft40">NACA)</p> <p style="position:absolute;top:277px;left:196px;white-space:nowrap" class="ft40">N-(2-fenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)metyl)-1H-indazol-</p> <p style="position:absolute;top:294px;left:181px;white-space:nowrap" class="ft40">3-karboxamid (CUMYL-THPINACA)</p> <p style="position:absolute;top:312px;left:196px;white-space:nowrap" class="ft40">(1-(5-fluoropentyl)-1H-indazol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-</p> <p style="position:absolute;top:329px;left:181px;white-space:nowrap" class="ft40">non (FAB-144)</p> <p style="position:absolute;top:346px;left:196px;white-space:nowrap" class="ft40">N-(adamant-1-yl)-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (FUB-</p> <p style="position:absolute;top:364px;left:181px;white-space:nowrap" class="ft40">AKB48)</p> <p style="position:absolute;top:381px;left:196px;white-space:nowrap" class="ft40">metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3-metylbutanoat</p> <p style="position:absolute;top:399px;left:181px;white-space:nowrap" class="ft40">(FUB-AMB)</p> <p style="position:absolute;top:416px;left:196px;white-space:nowrap" class="ft40">metyl-2-([1-(5-fluoropentyl)-1H-indol-3-yl]karboxamido)-3-metylbu-</p> <p style="position:absolute;top:433px;left:181px;white-space:nowrap" class="ft40">tanoat (I-AMB)</p> <p style="position:absolute;top:451px;left:196px;white-space:nowrap" class="ft40">metyl-2-(1-(cyklohexylmetyl)-1H-indol-3-karboxamido)-3,3-dimetylbu-</p> <p style="position:absolute;top:468px;left:181px;white-space:nowrap" class="ft40">tanoat (MMB-CHMINACA, MDMB-CHMICA)</p> <p style="position:absolute;top:486px;left:196px;white-space:nowrap" class="ft43">(4-metylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)metanon (mepirapim)<br/>naftalen-1-yl-1-(5-fluoropentyl)-1H-indol-3-karboxylat (NM-2201)<br/>N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-kar-</p> <p style="position:absolute;top:538px;left:181px;white-space:nowrap" class="ft40">boxamid (PX-1)</p> <p style="position:absolute;top:555px;left:196px;white-space:nowrap" class="ft40">N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-</p> <p style="position:absolute;top:573px;left:181px;white-space:nowrap" class="ft40">karboxamid (PX-2)</p> <p style="position:absolute;top:590px;left:196px;white-space:nowrap" class="ft43">naftalen-1-yl-(1-pentyl-1H-indazol-3-yl)metanon (THJ-018)<br/>1-(3,4-metylendioxifenyl)-2-(pyrrolidin-1-yl)butan-1-on (MDPBP)<br/>2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)butan-1-on (alfa-PBT)<br/>2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)pentan-1-on (alfa-PVT)<br/>1-(4-metylfenyl)-2-(pyrrolidin-1-yl)hexan-1-on (MPHP)<br/>1-(4-klorofenyl)-2-(pyrrolidin-1-yl)propan-1-on (4Cl-alfa-PPP)<br/>1-fenyl-2-(pyrrolidin-1-yl)hexan-1-on (alfa-PHP)<br/>1-fenyl-2-(pyrrolidin-1-yl)heptan-1-on (alfa-PEP)<br/>1-(2,3-dihydro-1-bensofuran-5-yl)propan-2-amin (5-APDB)<br/>1-(2,3-dihydro-1-bensofuran-6-yl)propan-2-amin (6-APDB)<br/>1-(1-bensofuran-6-yl)-N-metylpropan-2-amin (6-MAPB)<br/>2-(etylamino)-1-(4-metylfenyl)pentan-1-on (N-etyl-4-metylnorpente-</p> <p style="position:absolute;top:799px;left:181px;white-space:nowrap" class="ft40">dron)</p> <p style="position:absolute;top:816px;left:196px;white-space:nowrap" class="ft40">metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karboxamido)-3,3-dimetylbu-</p> <p style="position:absolute;top:834px;left:181px;white-space:nowrap" class="ft40">tanoat (5F-MDMB-PINACA)</p> <p style="position:absolute;top:851px;left:196px;white-space:nowrap" class="ft40">[1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indol-3-yl](2,2,3,3-tetrametylcy-</p> <p style="position:absolute;top:868px;left:181px;white-space:nowrap" class="ft40">klopropyl)metanon (A-834735)</p> <p style="position:absolute;top:886px;left:196px;white-space:nowrap" class="ft40">N-(adamantan-2-yl)-1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indazol-3-</p> <p style="position:absolute;top:903px;left:181px;white-space:nowrap" class="ft40">karboxamid (adamantyl-THPINACA)</p> </div> <div id="page5-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:649px;white-space:nowrap" class="ft50">5</p> <p style="position:absolute;top:51px;left:536px;white-space:nowrap" class="ft51"><b>SFS 2015:245</b></p> <p style="position:absolute;top:51px;left:91px;white-space:nowrap" class="ft50">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-indol-</p> <p style="position:absolute;top:68px;left:77px;white-space:nowrap" class="ft50">3-karboxamid (ADB-CHMICA)</p> <p style="position:absolute;top:85px;left:91px;white-space:nowrap" class="ft50">N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(4-fluorobensyl)-1H-indazol-3-</p> <p style="position:absolute;top:103px;left:77px;white-space:nowrap" class="ft50">karboxamid (APP-FUBINACA)</p> <p style="position:absolute;top:120px;left:91px;white-space:nowrap" class="ft52">naftalen-1-yl-(9-pentyl-9H-karbazol-3-yl)metanon (EG-018)<br/>(1-(4-fluorobensyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-</p> <p style="position:absolute;top:155px;left:77px;white-space:nowrap" class="ft50">non (FUB-144)</p> <p style="position:absolute;top:172px;left:91px;white-space:nowrap" class="ft52">kinolin-8-yl-1-pentyl-1H-indazol-3-karboxylat (PB-22 indazol)<br/>salvinorin A<br/>alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit ex-</p> <p style="position:absolute;top:225px;left:77px;white-space:nowrap" class="ft50">traherat och oavsett under vilka ben�mningar de f�rekommer</p> <p style="position:absolute;top:259px;left:91px;white-space:nowrap" class="ft50">Salter av �mnena n�r s�dana kan f�rekomma.</p> </div> <div id="page6-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:946px;left:529px;white-space:nowrap" class="ft60">Norstedts Juridik AB/Fritzes</p> <p style="position:absolute;top:956px;left:534px;white-space:nowrap" class="ft60">Elanders Sverige AB, 2015</p> </div> </div> ;